Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL723172 | 0.96 | ALDH1A1 (0.35) | ALDH1A1TSHRTP53CYP2D6CYP2C19 | |
| SCHEMBL17480770 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL7081652 | 0.78 | FFAR3 (0.35) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Benzene SCHEMBL7029282 | 0.74 | GRM2 (0.32) | ALDH1A1TSHR | |
| SCHEMBL5178000 | 0.74 | TET2 (0.33) | — | |
| SCHEMBL16418496 | 0.72 | CYP2C19 (0.44) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Chloroform SCHEMBL5415078 | 0.70 | MEN1 (0.30) | ALDH1A1 | |
| SCHEMBL17818653 | 0.69 | FFAR3 (0.39) | ALDH1A1TSHRTP53CYP2D6CYP2C19 | |
| SCHEMBL2521160 | 0.69 | ARG2 (0.35) | ALDH1A1TSHRTP53 | |
| SCHEMBL544392 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9683123-B2 | Silver ink | PESOLVE CO., LTD. (KR) | 2017-06-20 | — | — | US | disclosed |
| US-20160168408-A1 | SILVER INK | PESOLVE CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168408-A1 | SILVER INK | TP53, MKI67, NRAS | ALDH1A1 23/4885TSHR 4766/4885TP53 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.